BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH – Get Free Report) was the target of a large drop in short interest during the month of September. As of September 30th, there was short interest totaling 2,320 shares, a drop of 67.3% from the September 15th total of 7,084 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 24,423 shares, the short-interest ratio is currently 0.1 days.
BioForce Nanosciences Stock Performance
Shares of BFNH opened at $8.20 on Tuesday. The firm has a fifty day moving average of $6.10 and a 200-day moving average of $2.85. The company has a market cap of $312.14 million, a price-to-earnings ratio of 820.82 and a beta of 0.63. BioForce Nanosciences has a 1 year low of $0.18 and a 1 year high of $10.99.
BioForce Nanosciences (OTCMKTS:BFNH – Get Free Report) last posted its earnings results on Monday, August 10th. The company reported $0.01 EPS for the quarter.
About BioForce Nanosciences
BioForce Nanosciences, Inc develops nanotechnology tools and systems designed for research in life sciences, materials science and related fields. The company’s technologies are intended to support the controlled manipulation, deposition and analysis of very small quantities of biological and chemical materials.
Its product portfolio has included nanoscale patterning and fluid-handling systems, including the Nano eNabler platform. These tools are designed for applications such as creating biological arrays, depositing samples and reagents, and conducting research involving cells, proteins, DNA and other materials at the micro- and nanoscale.
BioForce Nanosciences was based in the United States and focused primarily on serving scientific, academic and industrial research markets.
Featured Stories
- Five stocks we like better than BioForce Nanosciences
- Salesforce Just Got a Rare Double Upgrade—What Changed?
- OpenAI’s Revenue Scare Could Be a Big Opportunity for Investors
- China Still Dominates Rare Earths—These 3 U.S. Companies Could Benefit
- 3 REITs That May Win in a Higher Interest Rate Environment
Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.
